Kenneth E. Remy

This study uses ELISpot to assess immunomodulatory drug effects on cytokine production in sepsis patients and healthy controls.

This study examines inflammatory and transcriptomic changes in the myocardium of mice after cardiac arrest, finding increased neutrophils and cytokines that resolve over time, correlating with improved cardiac function.

This study develops and optimizes a diluted whole blood ELISpot assay to assess immune function in septic patients, showing it can measure cytokine responses under various conditions.

This study shows that sulopenem combined with cefuroxime or durlobactam synergistically inhibits Mycobacterium abscessus, with BLIs enhancing antibacterial effects.

This study uses ELISpot to track changes in innate and adaptive immunity during sepsis and shows it can detect immune therapy effects.